[Rational therapy with G-CSF and GM-CSF].
作者信息
Link H, Herrmann F, Welte K, Aulitzky W E, Ganser A, Kern W V, Meyer P, Schrappe M, Schmoll H J, Werdan K
机构信息
Abteilung Hämatologie und Onkologie, Medizinische Hochschule Hannover.
出版信息
Med Klin (Munich). 1994 Aug 15;89(8):429-41.
PMID:7526144
Abstract
摘要
相似文献
1
[Rational therapy with G-CSF and GM-CSF].
Med Klin (Munich). 1994 Aug 15;89(8):429-41.
2
[Integration of G-CSF in prevention and therapy of neutropenic fever].[粒细胞集落刺激因子在中性粒细胞减少性发热预防和治疗中的应用]
Med Klin (Munich). 1996 Feb 15;91(2):82-8.
3
Therapeutic use of colony stimulating factors for established neutropenic fever.集落刺激因子在已确诊的中性粒细胞减少性发热中的治疗应用。
W V Med J. 1998 Jan-Feb;94(1):26-8.
4
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.粒细胞集落刺激因子和粒细胞-巨噬细胞集落刺激因子：比较及在非中性粒细胞减少患者感染治疗中的应用潜力
J Infect Dis. 1999 Mar;179 Suppl 2:S342-52. doi: 10.1086/513857.
5
[New, in Austria registered specialty drugs. Neupogen (G-CSF)].[新的，在奥地利注册的专科药物。优保津（粒细胞集落刺激因子）]
Wien Klin Wochenschr. 1991;103(21):661-6.
6
Granulocyte colony-stimulating factors.粒细胞集落刺激因子
Med Lett Drugs Ther. 1991 Jun 28;33(847):61-3.
7
Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.从粒细胞集落刺激因子改为粒细胞-巨噬细胞集落刺激因子的处方变更对接受骨髓抑制性化疗患者结局的影响。
Pharmacotherapy. 2005 Mar;25(3):372-8. doi: 10.1592/phco.25.3.372.61608.
8
Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
J Med Assoc Ga. 1992 Aug;81(8):437-41.
9
[Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].[粒细胞集落刺激因子（GM-CSF和G-CSF）的临床应用]
Med Pregl. 1997 Mar-Apr;50(3-4):87-93.
10
Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).接受恶性疾病强化化疗患者的造血生长因子：粒细胞集落刺激因子（G-CSF）、粒细胞-巨噬细胞集落刺激因子（GM-CSF）、白细胞介素-3（IL-3）和Flt-3配体（Flt3L）的研究。
Eur Cytokine Netw. 2001 Apr-Jun;12(2):231-8.
引用本文的文献
1
[Febrile neutropenia: practical aspects].[发热性中性粒细胞减少症：实际问题]
Med Klin (Munich). 1998 Oct 15;93(10):598-611. doi: 10.1007/BF03042675.
Zotero 插件